What Are The Mechanism Of Action, Optimal Wavelengths, And Safety Profiles Of Mid-Infrared Nonablative Lasers For Atrophic Acne Scar Treatment?

Mid-infrared nonablative lasers treat atrophic acne scars by heating the dermis without removing the epidermis. The principal wavelengths are 1320 nm, 1450 nm, and 1540 nm, which are absorbed primarily by dermal water and generate controlled thermal injury that stimulates collagen remodeling. Integrated epidermal cooling limits surface damage, producing low downtime and a comparatively favorable safety profile, including for darker Fitzpatrick skin types.

Core takeaway: Mid-infrared nonablative lasers are best suited to gradual improvement of mild-to-moderate atrophic acne scars when safety and minimal downtime are priorities. They usually require multiple sessions, and their results are more modest and slower than those of aggressive ablative resurfacing.

How Mid-Infrared Nonablative Lasers Work

Dermal water is the primary target

At 1320, 1450, and 1540 nm, laser energy penetrates beneath the epidermis and is absorbed largely by water in the dermis.

This raises tissue temperature, commonly to above approximately 50°C, producing controlled, diffuse thermal injury rather than vaporizing tissue.

Thermal injury stimulates collagen remodeling

The heat creates a wound-healing response without open de-epithelialized surfaces. Fibroblasts are stimulated to produce and reorganize collagen, gradually improving dermal support beneath depressed scars.

Thermal remodeling may also alter fibrotic tissue and contract portions of the scar’s fibrous attachments, although deeply tethered scars may require a mechanical treatment such as subcision.

Epidermal cooling protects the surface

Dynamic or contact cooling reduces heat accumulation in the epidermis while allowing energy to build in the dermis.

This combination—deep heating with surface protection—is the central design principle behind the safety of these systems.

Which Wavelengths Are Most Relevant?

1320 nm: deeper dermal thermal remodeling

The 1320 nm Nd:YAG wavelength is used to deliver nonablative dermal heating with limited epidermal disruption.

It is commonly considered when the objective is collagen remodeling in mild-to-moderate atrophic scars, particularly where minimal downtime is important.

1450 nm: water-targeted superficial-to-mid-dermal heating

The 1450 nm diode wavelength targets water in subsurface skin layers, often approximately 200–500 micrometers beneath the surface, depending on the device and treatment parameters.

It can improve atrophic texture through collagen remodeling and may also reduce sebaceous gland activity, making it useful when acne activity or enlarged pores accompany scarring.

1540 nm: fractional Er:Glass remodeling

The 1540 nm Er:Glass wavelength is another water-absorbed option for nonablative dermal remodeling.

Fractional delivery creates microscopic treatment zones while leaving surrounding skin intact, which supports faster recovery than fully ablative resurfacing.

Is one wavelength universally optimal?

No. Wavelength alone does not determine effectiveness. Penetration depth, pulse duration, fluence, spot size, cooling method, fractional versus nonfractional delivery, scar morphology, and skin phototype all influence the result.

A practical selection is therefore:

1320 nm when deeper nonablative dermal heating is desired.
1450 nm when water-targeted remodeling and possible sebaceous-gland effects are useful.
1540 nm when fractional Er:Glass treatment is preferred for controlled collagen remodeling.

The best choice depends on whether the scars are shallow rolling scars, deeper boxcar scars, or tethered scars. Nonablative lasers are generally less effective as a standalone treatment for sharply edged or deeply bound scars.

Where does 1064 nm fit?

The 1064 nm Nd:YAG is often grouped with nonablative infrared systems, but it is technically near-infrared rather than mid-infrared.

It can provide dermal heating with epidermal preservation, but the core mid-infrared scar-treatment range is more accurately described as 1320–1540 nm.

What Clinical Results Should Patients Expect?

Improvement is gradual

Collagen remodeling continues after treatment, so visible improvement may develop over several months.

Maximum visible benefit is often assessed around three to six months after a treatment series, rather than immediately after the final session.

Multiple sessions are usually necessary

Typical protocols involve approximately three to five sessions, often spaced about four weeks apart. Some protocols use intervals ranging from two to six weeks, depending on the device and treatment intensity.

A single session rarely produces the full expected result.

Results are meaningful but not equivalent to ablative resurfacing

Nonablative treatment commonly produces gradual softening and textural improvement rather than complete scar removal.

Reported clinical improvement may average approximately 40% to 50%, although outcomes vary substantially with scar type, treatment settings, baseline severity, and combination therapy.

Maintenance may be needed

Some improvement can diminish during longer follow-up, including over approximately 12 months.

Periodic maintenance treatments may therefore be considered when the goal is to preserve collagen density and texture gains.

How Safe Are These Lasers?

Epidermal preservation reduces common resurfacing risks

Because the epidermis is not intentionally vaporized, nonablative treatment generally causes less bleeding, crusting, and wound care than ablative CO₂ or Er:YAG resurfacing.

The absence of an open wound also reduces infection risk and shortens recovery.

Downtime is usually limited

Expected short-term effects include:

Mild erythema
Transient edema
Warmth or tenderness
Occasional temporary surface sensitivity

Many patients can resume normal activities quickly, although the exact downtime depends on fluence, pulse structure, fractional density, and individual response.

Darker skin types are generally better candidates than for aggressive ablation

Nonablative mid-infrared systems are relatively less pigment-sensitive than many ablative resurfacing approaches.

They therefore have a lower risk of post-inflammatory hyperpigmentation, hypopigmentation, and permanent scarring, which can make them suitable for a broader range of Fitzpatrick skin types.

However, “lower risk” does not mean “no risk.” Excessive fluence, inadequate cooling, active inflammation, recent tanning, or poor aftercare can still cause pigmentary or thermal complications.

Cooling is a safety-critical component

Cooling is not merely a comfort feature. It protects the epidermis from excessive heat and helps concentrate the thermal effect in the dermis.

For 1450 nm systems, reported examples include settings around 8 J/cm² with approximately 25 ms of dynamic cooling through 14 J/cm² with approximately 40–45 ms of cooling, but these are device-specific reference ranges—not universal prescriptions.

Understanding the Trade-offs

Lower downtime means slower remodeling

The same epidermal preservation that improves safety also limits the amount of tissue that can be removed or aggressively remodeled.

Patients should expect gradual change rather than the rapid resurfacing effect associated with ablative lasers.

Deep scars may need combination treatment

Nonablative heating does not physically release every fibrous tether or reconstruct substantial volume loss.

Deep rolling scars may respond better when treatment is combined with procedures such as subcision, while selected scars may benefit from dermal-stimulating injectables or other appropriately chosen therapies.

More treatment intensity is not automatically better

Increasing fluence or reducing cooling may increase thermal injury without producing proportionally better remodeling.

Overtreatment can raise the risk of prolonged erythema, burns, post-inflammatory hyperpigmentation, and texture abnormalities.

Treatment settings cannot be copied between devices

A fluence value has meaning only in relation to the device’s wavelength, pulse duration, spot size, cooling system, and delivery mode.

Protocols should therefore be individualized by an experienced clinician rather than transferred directly from another laser platform.

Active acne should be addressed separately

A 1450 nm system may reduce sebaceous gland activity and can be useful when inflammatory acne coexists with scarring.

Nevertheless, ongoing acne control remains important because new lesions can create additional scars and undermine the cosmetic result.

Making the Right Choice for Your Goal

The appropriate approach depends on the balance between scar severity, desired improvement, skin phototype, and tolerance for downtime.

If your primary focus is minimal downtime and broad skin-type safety: Consider a mid-infrared nonablative platform with careful epidermal cooling, understanding that several sessions are usually required.
If your primary focus is gradual collagen remodeling: Discuss 1320 nm, 1450 nm, or 1540 nm treatment based on the device’s penetration and delivery characteristics rather than wavelength alone.
If your primary focus is deep rolling or tethered scars: Ask whether subcision or another mechanical treatment should be combined with nonablative laser therapy.
If your primary focus is the greatest possible single-course correction: Compare nonablative treatment with fractional ablative resurfacing, accepting the latter’s greater downtime and pigmentary risk.
If your primary focus is treating scars alongside oily or inflammatory acne: A 1450 nm system may offer additional sebaceous-gland effects, but acne control should remain part of the treatment plan.

Mid-infrared nonablative lasers offer a rational compromise: meaningful dermal remodeling with substantially less surface injury, provided expectations and treatment parameters are carefully matched to the scar pattern.

Summary Table:

Wavelength	Target	Peak Depth	Primary Use	Typical Sessions	Downtime
1320 nm (Nd:YAG)	Dermal water	~200-500 µm	Deeper dermal remodeling	3-5	Minimal
1450 nm (Diode)	Water, sebaceous glands	~200-500 µm	Superficial-mid dermal remodeling, acne	3-5	Minimal
1540 nm (Er:Glass)	Dermal water	~200-500 µm	Fractional remodeling	3-5	Minimal

Ready to explore nonablative laser solutions for your clinic? BELIS offers advanced mid-infrared laser systems (1320 nm, 1450 nm, 1540 nm) designed for safe and effective atrophic acne scar treatment. Our professional-grade equipment is trusted by clinics and premium salons worldwide. With competitive pricing, OEM/ODM support, and full certifications, we help you expand your service offerings and boost profitability. Enhance your patients' results and grow your business today—contact us for a personalized consultation.